Geneva, Switzerland – 19 September 2018 – We are pleased to announce that AMAL Therapeutics is featured in the September edition of BioPharma Dealmakers (Nature Research), outlining the promise of protein-based therapeutics cancer vaccine in oncology. View PDF
ESMO Immuno Oncology – Geneva 2018 13-16 December / Geneva / Switzerland Amal Therapeutics Team attending
BioFIT 2018 4-5 December / Lille / France Madiha Derouazi speaking
World Immunotherapy Congress 2018 29-31 October / Basel / Switzerland Madiha Derouazi speaking
ESMO – Munich 2018 19-23 October / Munich / Germany Madiha Derouazi attending
4th CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference 30 September – 3 October 2018 / New York, NY / USA Jean-François Mayol attending
IPO Day Lausanne 2018 13 June / Lausanne / Switzerland Madiha Derouazi attending
BIO International Convention 2018 4-7 June 2018 / Boston, MA / USA Madiha Derouazi attending
ASCO Annual Meeting 2018 1-5 June 2018 / Chicago, IL / USA Patricia Delaite attending
16th CIMT Annual Meeting 15-17 May 2018 / Mainz / Germany Jean-François Mayol attending
Amal Therapeutics SA
c/o Fondation pour Recherches Médicales
64 av. de la Roseraie
1205 Geneva
Switzerland
Website by Instinctif Partners